Genetically Modified Lactococcus lactis for Delivery of Human Interleukin-10 to Dendritic Cells
2012

Using Modified Bacteria to Deliver IL-10 for Immune Regulation

publication Evidence: moderate

Author Information

Author(s): Inge L. Huibregtse, Sebatian A. Zaat, Martien L. Kapsenberg, Maria A. Sartori da Silva, Maikel P. Peppelenbosch, Sander J. H. van Deventer, Henri Braat

Primary Institution: Academic Medical Center, Erasmus Medical Center, Leiden University Medical Center

Hypothesis

L. lactisIL-10 is able to modulate immature DC to become regulatory DC which in turn induce suppressor T cells.

Conclusion

The study suggests that the anti-inflammatory effect of L. lactisIL-10 is mediated through modulation of dendritic cell function.

Supporting Evidence

  • L. lactisIL-10 significantly improved the suppression of allogenic Th-cell proliferation by effector Th-cells.
  • DC matured with L. lactisIL-10 showed increased expression of CD83 and CD86.
  • The production of IL-10 was higher in L. lactisIL-10-derived DC compared to L. lactis-derived DC.

Takeaway

Scientists are using special bacteria to help the immune system calm down and stop attacking itself, which could help treat diseases.

Methodology

The study involved culturing dendritic cells with modified Lactococcus lactis that secretes IL-10 and assessing the effects on T-cell responses.

Limitations

The study primarily used in vitro methods, which may not fully replicate in vivo conditions.

Participant Demographics

Healthy volunteers provided peripheral blood for dendritic cell generation.

Statistical Information

P-Value

p<0.05

Confidence Interval

95%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2012/639291

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication